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Maladaptive substance use is a serious, prevalent concern, with especially high prevalence rates 
found in the male and young adult populations. Research shows certain personality and 
psychopathology traits are strongly correlated with externalizing behaviors, including 
maladaptive substance use. Insight into the relationship between trait characteristics and 
substance use patterns may have implications for treatment outcomes. The current study is one of 
the first to examine associations between Minnesota Multiphasic Personality Inventory-3 
(MMPI-3) traits and substance use on the Comprehensive Addictions and Psychological 
Evaluation, Fifth Edition (CAAPE-5). This study expands upon literature on the relationship 
between personality and psychopathology traits and use of alcohol and marijuana through 
correlational analysis of the MMPI-3 scales and CAAPE-5 data. Over two hundred college 
students participated, with findings demonstrating high rates of maladaptive substance use. The 
rate of overall substance use reported was lower than statistics from a nation-wide survey, but the 
current study sample displayed much higher rates of alcohol and cannabis use than seen in a 
nation-wide sample. Correlational analysis of MMPI-3 traits within the Behavioral/Externalizing 
Dysfunction domain revealed moderate to strong correlations with overall substance use and 
alcohol use. Aside from Demoralization, traits within the Emotional/Internalizing Dysfunction 
domain were insignificantly correlated with overall substance use and marijuana use. Gender 
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was not found to be a moderating effect on the association between Disconstraint and alcohol 
use. The findings from this study emphasize personality and psychopathology trait 
considerations when examining substance misuse among college students. Strong correlations 
between traits and substance misuse indicate treatment interventions that address individual 
characteristics that can influence substance misuse and vice versa may be beneficial. 




CHAPTER ONE: INTRODUCTION 
 
 Maladaptive substance use, referring to use of substances that has reached a level of 
concern as indicated by a probable substance use disorder, is a pervasive issue experienced at 
both individual and societal levels. A national survey conducted by the Substance Abuse and 
Mental Health Services Administration (SAMHSA) in 2019 revealed 20.4 million individuals in 
the United States met criteria for a substance use disorder (SAMHSA, 2020). This equates to 
nearly 7.5% of the population. Approximately 21.6 million, or about 1 in 13 individuals, needed 
treatment for their substance misuse. Unfortunately, only 2.1 million individuals received 
treatment related to their substance misuse. Current rates of substance use disorders vary based 
on age, but have remained stable when compared to rates in 2015 and 2019 (SAMHSA, 2020). 
 Maladaptive substance use impacts individuals of all racial/ethnic backgrounds, 
socioeconomic statuses, education levels, and ages, but for some populations the risk is relatively 
higher. Perhaps most concerning are the high prevalence rates within the young adult (ages 18-
25) population. SAMHSA (2020) revealed approximately 14% of young adults met criteria for a 
substance use disorder within the past year. Some studies show even higher rates, such as 39.6% 
for college students and 44.5% for young adults not enrolled in college (Arterberry, 2019). 
Disconcertingly, the young adult population is the least likely to seek treatment for their 
maladaptive substance use despite these inordinate rates. This is a major concern, as individuals 
who engage in maladaptive substance use but do not perceive the need for treatment are at an 
increased risk level for negative outcomes (Arterberry, 2019). 
 Alcohol and marijuana are among the substances with the highest rates of misuse among 
young adults. The prevalence of alcohol use disorder in individuals aged 18 to 25 has decreased 
from nearly 18% in 2002 to 9.3% in 2019 but alcohol-related problems remain a source of 
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concern. Binge-drinking is especially rife for this age group, with the highest prevalence for 
males age 22 at 53% and for females age 22 at 34% (Evans-Polce et al., 2018). Cannabis use 
disorder in the young adult age group was 5.8% in 2019 which is similar to rates in the past 
decade, but rates of marijuana use are climbing (SAMHSA, 2019).  
Gender and sex differences are important to examine when conducting research on 
substance use disorders but remain understudied (McHugh et al., 2018). Historically men have 
had higher rates of substance use disorders, but this gap in prevalence is closing. There is a rise 
in women’s substance misuse, perhaps due to the increased economic and social opportunities 
women are involved in today (Seedat et al., 2009). Men participate in substance misuse earlier 
than women, and more often display riskier behaviors such as binge drinking and illicit drug use 
(McHugh et al., 2018). Women tend to begin using substances later in life than men but are 
generally at higher risk for developing substance use-related problems. Increased impairment in 
daily functioning is reported by women receiving treatment for substance use disorders, yet adult 
females are less likely to receive treatment. Women are also less likely than males to receive 
specialized substance use disorder treatment (McHugh et al., 2018).  
Paradigm Shift 
 The field of psychology has largely employed a categorical approach towards classifying 
and diagnosing psychopathology. The rationale for this is understandable; it allows for 
simplicity, clarity, and satisfies the innate human appreciation for categorization. Objective 
dichotomous criteria can allow for a more straight-forward depiction of mental illness 
(Witkiewitz et al., 2013). In the past couple of decades, however, the flaws of the categorical 
approach have raised concern and invited scrutiny of our current classification system. 
 Limitations of the categorical approach include the low interrater reliability between 
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diagnoses in the Diagnostic and Statistical Manual of Mental Disorders – Fifth Edition (DSM-5). 
Nearly half do not have acceptable levels of interrater reliability (Regier et al., 2013). Treatment 
for symptomatology can be hard to distinguish due to the high comorbidity between diagnoses 
(Mitchell et al., 2020). When considering the characteristics of mental disorders, it becomes clear 
that individuals experience symptoms along a continuum rather than in distinct boxes set by 
certain criteria (Widiger & Mullins-Sweatt, 2007).  
 Research shows that dimensional measures of psychopathology are more reliable and 
valid than categorical measures. This holds true for substance use disorders as well. Individuals 
who have a substance use disorder are more susceptible to exhibiting externalizing behaviors. 
This vulnerability is best represented on a dimensional spectrum (Witkiewitz et al., 2013). Since 
individuals vary significantly on levels of self-control, there is no clear criterion cut-off for 
constructs related to externalizing behaviors such as maladaptive substance use. Therefore, 
externalizing dysfunction in general is best captured when using a dimensional approach 
(Widiger & Mullins-Sweatt, 2007) 
For current diagnostic purposes, the categorical coding approach is necessary for various 
reimbursement and program eligibility objectives. However, in the near future the need for more 
accurate discernment of psychiatric symptomatology and psychopathology may warrant 
replacement of the categorical system. For the present, categorically-based and dimensionally-
focused assessments can be used in tandem to provide a comprehensive understanding of the 
client conceptualization. 
The MMPI Instruments 
 The Minnesota Multiphasic Personality Inventory (MMPI) instruments have long been 
considered primary measures of personality characteristics and psychopathology. They have 
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been widely used in mental health, medical, and forensic settings, as well as for personnel 
selection and promotion purposes. Hathaway and McKinley’s (1943) intention behind the 
development of the MMPI was to clarify the diagnostic process for physicians working in a 
clinical setting. Ideally, their empirical keying approach would result in elevations on 
empirically-derived scales that would then lead to one of 10 specific diagnostic groups. Although 
the assessment failed in this aspect, it proved a useful tool and established itself among the most 
frequently-used personality inventories. A resulting wealth of research also stemmed from the 
creation of the MMPI, leading to increased understanding of personality and psychopathology 
(Sellbom, 2019).   
  To address the original MMPI’s outdated and homogenous normative sample, 
restandardization based upon 2,600 protocols produced the Minnesota Multiphasic Personality 
Inventory-2 (MMPI-2) in 1989. New Content Scales provided the ability to measure additional 
constructs, but the original validity and clinical scales remained fairly unaltered, much to the 
relief of those who did not wish for the MMPI to be modified (Ben-Porath, 2012). However, this 
meant the issue of extensive item overlap was not attended to until 2003, with the development 
of the Restructured Clinical (RC) Scales. The culprit behind the significant overlap was the 
underlying factor of Demoralization. Once Demoralization was separated from each scale and 
made a core component, more focused forms of each scale were constructed targeting the major 
distinctive core construct. Factor analysis was used to create the final scales (McCord, 2018).  
The most recent version of the MMPI instruments is the Minnesota Multiphasic 
Personality Inventory-3 (MMPI-3; Ben-Porath & Tellegen, 2020), consisting of 335 items and 52 
scales. The MMPI-3 was released in fall 2020 and features a new normative sample of 1,620 
individuals that aligns with the 2020 U.S. Census. Along with addressing the need to update the 
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norms, a goal of developing the MMPI-3 was to enhance the content. This is reflected in scale 
refinements, including the addition of several new scales and deletions and modification of some 
of the existing MMPI-2-RF scales. A normative sample of 550 Spanish-speaking individuals was 
also collected for development of the first Spanish translation. With the updated normative 
sample, there are a few differences in the norms resulting in lower T-scores for some validity 
scales and the Somatization scales (Pearson Assessments, 2020).  
The hierarchical model of the MMPI-3 offers a coherent depiction of the personality and 
psychopathology constructs it assesses (see Figure 1 below). The tiered structure of scales is in 
order from least to most specific. At the top of the model are five domains (in order from left to 
right): Somatic/Cognitive, Emotionalizing/Internalizing, Thought Dysfunction, 
Behavioral/Externalizing, and Interpersonal Functioning. Within the 
Emotionalizing/Internalizing, Thought Dysfunction, and Behavioral/Externalizing domains are 
the broad Higher-Order scales with the same respective names. (Pearson Assessments, 2020).  
The Somatic/Cognitive Domain includes the Somatic Complaints (RC1) Scale and the 
more specific Malaise, Neurological Complaints, Eating Concerns, and Cognitive Complaint 
scales. The next domain, Emotional/Internalizing Dysfunction, includes three RC scales: 
Demoralization (RCd), Low Positive Emotions (RC2), and Dysfunctional Negative Emotions 
(RC7). These scales under RCd are: Suicide/Death Ideation, Helplessness/Hopelessness, Self-
Doubt, and Inefficacy. Under RC2 is Introversion/Low Positive Emotions, and below RC7 are 
the Stress, Worry, Compulsivity, Anxiety-Related Experiences, Anger Proneness, Behavior 
Restricting Fears, and Multiple Specific Fears. Behavioral/Externalizing Dysfunction represents 
several types of externalizing behaviors; the more specific scales under this parent scale include 
many of the ones of interest in the current study. At the mid-level, the RC scales under this 
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parent scale are Antisocial Behavior (RC4), Hypomanic Activation (RC9), and Disconstraint. 
Under RC4 are the facet scales Family Problems, Juvenile Conduct, and Substance Abuse. 
Below RC9 is Impulsivity, Activation, Aggression, and Cynicism. The Interpersonal Functional 
domain houses the Self-Importance, Dominance, Aggressiveness, Disaffiliativeness, Social 
Avoidance, and Shyness scales (Ben-Porath & Tellegen, 2020).  
Figure 1 
MMPI-3 Model of Psychopathology. 
 
 
Note. Scales of interest highlighted in blue. 
Association between Personality/Psychopathology and Maladaptive Substance Use 
Previous research investigating personality traits of individuals diagnosed with a 
substance use disorder has found disinhibition to be a highly heritable underlying factor of 
substance misuse (Joyner et al., 2019; Kotov et al., 2010). Disinhibition is a broad dimension that 
appears in several personality models. Tellegen (1985) considered low agreeableness and low 
conscientiousness to be key components of disinhibition (Mullins-Sweatt et al., 2019). The 
DSM-5 explains that individuals who exhibit disinhibition may be predisposed to substance use 
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disorders due to impaired inhibitory mechanisms (American Psychiatric Association, 2013). In 
the DSM-5’s proposed Alternative Model of Personality Disorders (AMPD), a model reflecting 
both dimensional and categorical characteristics, disinhibition encompasses impulsivity, 
irresponsibility, risk-taking, distractibility, and a lack of perfectionism (Mullins-Sweatt et al., 
2019). High levels of disinhibition and impulsivity are seen in individuals who exhibit antisocial 
behavior, perhaps due to overarching externalizing dysfunction. Unsurprisingly, antisocial 
behavior has been shown to be associated with substance use disorders (Brennan et al., 2017) 
and the interaction of those conditions should be examined and addressed in treatment.  
On the MMPI-3, the Personality Psychopathology Five (PSY-5) Scales assess cognitive 
reality, such as psychoticism, and dynamic emotion (Harkness et al., 2013). The Disconstraint 
Scale captures lack of self-control and sensation and excitement-seeking behaviors, the 
predominant characteristics of disinhibition (McCord, 2018). Bryant and McNulty (2017) found 
Disconstraint to be the strongest predictor of substance misuse out of the PSY-5 scales.  
Personality traits have also been linked to specific substance misuse-related problems. 
Disconstraint has been found to correlate with maladaptive use of alcohol, marijuana, cocaine, 
and heroin (Harkness et al., 2013). Traits encapsulating impulsive and disinhibiting behaviors 
tend to be associated with certain substance-use related behaviors. Research finds that response 
inhibition deficits in individuals who act impulsively are linked to a tendency to misuse alcohol 
and stimulants (Conrod, 2016; Littlefield & Sher, 2016). Sensation-seeking is associated with 
alcohol and marijuana use (Mullins-Sweatt et al., 2019). Individuals who display sensation-
seeking behaviors are motivated to engage in substance use through incentive reward and 
demonstrate an increased sensitivity to the pharmacological effects of alcohol (Conrod, 2016). 
Internalizing traits and behaviors are also important to consider in regard to misuse of particular 
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substances. Individuals who struggle with feelings of hopelessness have been found to use 
marijuana (Pearson et al., 2018). Other research has found high rates of co-occurrence between 
anxiety disorders and cannabis use (e.g., Kedzior & Laeber, 2014; Pasche, 2012). There is 
evidence for a bidirectional effect of marijuana use on symptoms of anxiety, but little is known 
about the directionality of this relationship. The prevalence of marijuana use and anxiety 
disorders among young adults warrants further research on this association.  
Knowledge of personality and how it affects individuals’ substance misuse and related 
behaviors could be crucial in identifying effective and lasting interventions. Although it may be 
futile to attempt changes to individuals’ personality characteristics as a way to reduce or 
eliminate substance misuse, information of traits and affiliated motives could be advantageous 
for successful treatment. Generally, these motives are coping strategies that can be successfully 
targeted through empirically-based transdiagnostic approaches (Helle et al., 2016; Littlefield & 
Sher, 2016). 
Research shows treatment interventions that are matched to personality characteristics or 
specifically address personality factors that affect substance use patterns may improve treatment 
outcomes (Staiger et al., 2007). For example, treatment-seeking behaviors and outcomes for 
individuals who only have symptomatology of alcohol use disorder can look very different from 
that of individuals diagnosed with alcohol use disorder and another psychiatric disorder (Helle et 
al., 2019). Therefore, treatment approaches may necessitate special consideration for individuals 
who require interventions for co-occurring conditions. Measures that assess narrow facets of 
personality and psychopathology, such as the MMPI-3, could be useful in both research and 
treatment contexts to further distinguish the underlying motives of individuals’ problematic 




The upcoming release of the MMPI-3 allows the opportunity to compare it with an 
external criterion measure of substance use to determine patterns of convergent and divergent 
correlations. As previous research has shown, information of individuals’ personality and 
psychopathology characteristics, especially related to disinhibition, may be a valuable tool in 
tackling problematic substance misuse. The MMPI-3 is used to examine the association between 
personality and psychopathology traits and maladaptive substance use. Expressly, 
behavioral/externalizing dysfunction and emotional/internalizing dysfunction are compared to 
patterns of substance use. This study expands upon the literature on the association between 
specific personality and psychopathology traits and misuse of particular substances. Due to the 
high rates of alcohol and marijuana use among college students, these two substances were 
focused upon for this study. Given prior research on gender differences regarding the link 
between disinhibition and externalizing disorders (Hicks et al., 2007), the moderating effect of 
gender on the MMPI-3 Disconstraint scale and alcohol use was also examined.  
Hypotheses 
Hypothesis 1. It is hypothesized that MMPI-3 Behavioral/Externalizing Dysfunction 
domain scores will be correlated with substance use risk as indicated by the CAAPE-5. 
1a. There will be a significant positive correlation between the MMPI-3 
Behavioral/Externalizing Dysfunction scale (BXD) and substance use risk as 
indicated by the CAAPE-5. 
1b. There will be a significant positive correlation between the MMPI-3 




1c. There will be a significant positive correlation between the MMPI-3 
Hypomanic Activation scale (RC9) and substance use risk as indicated by the 
CAAPE-5. 
1d. There will be a significant positive correlation between the MMPI-3 
Substance Abuse scale (SUB) and substance use risk as indicated by the CAAPE-
5.   
 Hypothesis 2. It is hypothesized that CAAPE-5 substance use scores will be positively 
correlated with MMPI-3 scores within the Emotional/Internalizing Dysfunction domain. 
2a. There will be a significant positive correlation between the MMPI-3 
Emotional/Internalizing Dysfunction scale (EID) and substance use risk as 
indicated by the CAAPE-5. 
2b. There will be a significant positive correlation between the MMPI-3 
Demoralization scale (RCd) and marijuana use as indicated by the CAAPE-5. 
2c. There will be a significant positive correlation between the MMPI-3 Anxiety-
Related Experiences scale (ARX) and marijuana use as indicated by the CAAPE-
5. 
2d. There will be a significant positive correlation between the MMPI-3 
Helplessness/Hopelessness scale (HLP) and marijuana use as indicated by the 
CAAPE-5. 
Hypothesis 3. It is hypothesized that correlations with specific MMPI-3 externalizing 
scales will be higher with alcohol use as indicated by the CAAPE-5. 
3a. There will be a significant positive correlation between the MMPI-3 
Disconstraint scale (DISC) and alcohol use as indicated by the CAAPE-5. 
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3b. There will be a significant positive correlation between the MMPI-3 
Impulsivity scale (IMP) and alcohol use as indicated by the CAAPE-5.  
 Hypothesis 4. Gender will have a moderating effect between Disconstraint and alcohol 
use, with a greater impact of this association on males. A statistical diagram of this moderation is 
shown below in Figure 2. 
Figure 2 


















CHAPTER TWO: METHOD 
Participants 
The sample consists of 210 undergraduate students from a medium-sized state 
comprehensive university in a rural, southeastern region of the United States. Students were 
recruited through the university psychology research pool and required to be 18 or older to 
participate. They received course credit for participating in this study. After excluding invalid 
MMPI-3 profiles (see Analyses section), the final sample was 205 participants. The majority 
were female (62.4%, n =128), age 18 (50.7%, n = 104), and unmarried (97.6%, n = 200). Over 
98% of the sample was between the ages of 18 and 25. Demographic information can be found in 
Table 2.  
Measures 
 Two empirically supported assessments within their respective areas of focus were used 
to ascertain a comprehensive conceptualization of the participants’ personality characteristics, 
psychological functioning, and substance use patterns. These measures are the MMPI-3 and the 
Comprehensive Addictions and Psychological Evaluation, Fifth Edition (CAAPE-5).  
Comprehensive Addictions and Psychological Evaluation, Fifth Edition 
 The CAAPE-5 (Hoffmann, 2013; See Appendix A) is a structured diagnostic interview 
made up of 150 items that assess substance use and common psychological disorders as defined 
by the DSM-5 (American Psychiatric Association, 2013). The CAAPE-5 demonstrates content 
validity by aligning with DSM-5 criteria and high reliability with the diagnostic subscales for 
substance use disorders featuring Cronbach’s alphas in the .90s (Procter & Hoffmann, 2012). 
The CAAPE-5’s extensive 39-item section on substance use goes above and beyond the majority 
of other measures of substance misuse by providing a complete picture of respondents’ substance 
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use history and current patterns. For the purposes of this study, only the substance use items of 
the interview were administered.  
Benefits of the CAAPE-5 include the ability to obtain a comprehensive behavioral health 
conceptualization of the respondent within about 30 minutes. The CAAPE-5 also provides 
information regarding the severity of substance misuse, with items categorized by DSM-5 
criteria. Test-takers receive higher scores for more items answered positively, reflecting higher 
reports of symptomatology. Scores obtained on the CAAPE-5 may translate to a DSM-5 
categorical diagnosis of a substance use disorder number of positive criteria met, with raw scores 
of at least two indicating a probable diagnosis of a substance use disorder (American Psychiatric 
Association, 2013). If risk is determined, levels of severity are classified as Mild, Moderate, and 
Severe, consistent with the DSM-5.  
Minnesota Multiphasic Personality Inventory – 3 
The norm-updated MMPI-3 is the latest of the MMPI instruments, assessing personality 
and psychopathology. The measure consists of 335 items, with test-takers responding in a 
dichotomous true/false fashion. Completion time ranges from 25 to 50 minutes, based on online 
or paper-and-pencil administration. The internal consistencies of the MMPI-3 traits examined in 
this study show substantial reliability. A list of Cronbach’s alphas for these traits can be found in 
Table 1.  
These data were collected in a combined effort that also included additional measures not 
utilized in the current study. These include an experimental version of the Multidimensional 
Behavioral Health Screen 2.0 (MBHS), Interpersonal Needs Questionnaire (INQ), Fearlessness 
About Death Scale, and Depressive Symptoms Inventory – Suicide Subscale (DSI-SS). 
Additional measures administered were the Childhood Trauma Questionnaire (CTQ), Eating 
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Disorder Examination (EDE-Q), an experimental version of an item set similar to the CTQ, an 
adult attachment questionnaire, and a structured interview regarding suicide risk assessment.  
Analytic Strategy 
 An a priori power analysis was conducted via G*Power (Faul et al., 2009) to 
ensure a suitable sample size; this indicated a sample size of 193 participants would yield 80% 
power assuming small-medium effects. Internal consistency among the MMPI-3 scales of 
interest in this study was examined using Cronbach’s alpha, with a value of >.8 determined to be 
sufficient. Correlational analysis via SPSS (IBM Corp., 2017) was used to examine associations 
with substance use as indicated by the CAAPE-5. Since severity classifications for probable 
substance use disorders as indicated by the CAAPE-5 were considered ordinal, Spearman’s 
correlation coefficients were computed. Participants were placed in one of the following severity 
classifications: No risk, Mild, Moderate, and Severe based on number of positive criteria met on 
the CAAPE-5. All substance use reported by participants was recorded, but only misuse of 
alcohol and marijuana was involved in the analyses. Rates of alcohol and marijuana use obtained 
from the study sample included data from the small number of participants who met criteria for 
both an alcohol use disorder and a cannabis use disorder.  
Since multiple correlation coefficients were calculated from the same dataset, the 
Bonferroni correction was applied resulting in an adjusted alpha level of p < .005 (0.05/10) for 
determining statistical significance. For the purposes of clinical significance, a minimum effect 
size of .30 was established for interpretation of correlation coefficients.  
 A moderation was examined using hierarchical multiple regression analysis in SPSS to 
assess the moderating variable of gender on alcohol misuse and Disconstraint. Descriptive 
statistics were examined to observe prevalence of overall elevated substance use, elevated 
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alcohol use, and elevated marijuana use between males and females. This allowed for 
exploratory observations of gender differences in level of severity. 
Procedure 
 Data collection commenced with an in-person format during the Spring 2020 semester. 
Upon arrival, participants were given a brief verbal explanation of the study procedure and risks 
involved and provided the informed consent form (see Appendix B) to read. Participants were 
offered a copy of the consent form to keep, along with a sheet of local psychological and medical 
services. Once consent was obtained, participants were administered the survey measures via 
Qualtrics, an online survey program. Once the survey was completed, the CAAPE-5 and Joiner 
Suicide Risk structured interviews were conducted. The study was concluded after any suicide-
related emergency was identified and addressed. If a participant was deemed high risk for 
suicide, a protocol outlined with the Western Carolina University Internal Review Board was 
followed. This included involving the Western Carolina University Counseling and 
Psychological Services, Issue Alert System, and local emergency services if necessary.  
 After data were collected from 31 participants in this format, the procedure was shifted to 
an online video conferencing platform Zoom due restrictions associated with the COVID-19 
pandemic. The remainder of the data were obtained through this modified remote data collection. 
Participants were emailed 24 hours prior to the session time with a copy of the informed consent 
document, local psychological and medical care resource document, and a HIPAA-compliant 
Zoom link specific for each participant. A brief verbal explanation of the study and overview of 
the consent form was provided. Once consent was obtained, participants completed the measures 
via Qualtrics, an online data collection platform. Upon completion, participants were interviewed 
based on the CAAPE-5 substance use-related items. Following the Joiner Suicide Interview, 
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participants at risk for suicide were connected with safety services as outlined in the protocol 




CHAPTER THREE: RESULTS 
 
 At the time data were extracted for the purposes of this research, a total of 210 
participants had completed the study. Five participants were excluded from the sample due to 
invalid MMPI-3 profiles as based on previously-determined cut-off scores. Analyses were run on 
the final sample of 205 participants.  
Descriptive Statistics 
 The CAAPE-5 interview provided information on the prevalence of substance use 
disorders among participants as determined by number of positive criteria met. Data were also 
collected on number of criteria met for an alcohol use disorder and/or cannabis use disorder. 
Over 28% (n = 58) of the participants met criteria for a substance use disorder as determined by 
the CAAPE-5. Approximately 25% (n = 51) of the sample reported maladaptive alcohol use that 
would suggest a likely alcohol use disorder and slightly over 14% (n = 29) reported a level of 
cannabis use that would indicate a probable cannabis use disorder. A complete list of severity 
classifications for participants who would likely meet criteria for a substance use disorder can be 
found in Table 3.  
 Elevated substance use among participants based on gender was also examined (see 
Table 4). Over 16% of the female participants and over 11% of the male participants reported 
elevated substance use. Of the sample, just over 14% of the female participants and nearly 11% 
of the male participants had a probable alcohol use disorder. Percentages were lower for 
participants with an anticipated cannabis use disorder, with approximately 8% of females and 6% 






 Correlational analysis of MMPI-3 trait correlations in the Behavioral/Externalizing 
Dysfunction domain and substance use yielded moderate correlations (see Table 5). Strong 
correlations were found between overall substance use and the Behavioral/Externalizing 
Dysfunction (r = .561, p < .001) and Antisocial Behavior scales (r = .531, p < .001). The 
Substance Abuse Scale was also strongly correlated with substance use, r = .539, p < .001. 
Hypomanic Activation and overall substance use were moderately correlated, r = .435, p < .001.  
Hypothesis II 
 Correlational analysis of MMPI-3 traits within the Emotional/Internalizing Dysfunction 
domain and substance use as determined by the CAAPE-5 revealed some significant but weak 
correlations (see Table 6). Demoralization and marijuana use were weakly correlated, r = .200, p 
= .004. With the conservative Bonferroni correction, Emotional/Internalizing Dysfunction and 
overall substance use were not significantly correlated, r = .144, p = .039. Marijuana use was not 
significantly correlated with the Anxiety-Related Experiences (r = .148 p = .034) and 
Helplessness/Hopelessness (r = .116, p = .099) scales.  
Hypothesis III 
 Two traits within the Behavioral/Externalizing Dysfunction domain were correlated with 
alcohol use. Disconstraint and alcohol use were strongly correlated, r = .545, p < .001 and 
Impulsivity and alcohol use were moderately correlated, r = .390, p < .001. These results can be 
found in Table 7.  
Hypothesis IV 
 In order to examine if the MMPI-3 Disconstraint scale predict elevated alcohol use, and if 
gender acts as a moderating variable, alcohol misuse was regressed onto Disconstraint, gender, 
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and the interaction between Disconstraint and gender (see Table 8). Semi-partial Pearson’s r (rsp) 
were reported as a measure of effect size for regression coefficients (Dudgeon, 2016). 
Disconstraint and gender were entered in the first step of the model, and the interaction term 
(Disconstraint x Gender) was entered into the second step. The first step of the model accounted 
for 34% of the variance, R2 = 0.34, F(2, 202) = 51.925, p < .001. In this first step, Disconstraint 
was positively and significantly associated with elevated alcohol use, B = .34,   = 0.59, t(202) = 
10.14, p < .001, 95% CI [0.27, 0.40], rsp = .58. Gender was not significantly associated with 
alcohol use, B = .09,   = 0.02, t(202) = 0.40, p = .687, 95% CI [-0.36, 0.54], rsp = .02. Adding 
the interaction term to the second step of the model accounted for no change in the variance, ΔR2 
= 0.00, F(1, 201) = 0.14, p = .714. In this second step, the interaction term was not significantly 
associated with alcohol use, B = -.03,   = -0.07, t(201) = -0.37, p = .714, 95% CI [-0.16, 0.11], 





CHAPTER FOUR: DISCUSSION 
 
 The data obtained from the CAAPE-5 interviews revealed a substance use disorder 
prevalence rate of just over 28%, which is within the range of prevalence rates found in the 
literature. This number is lower than what has been reported for college students, but is 
nevertheless alarmingly high. This lower rate could be due to limited access to substances due to 
several factors. The sample was composed of a large percentage of freshmen, who may not have 
the means to access substances for reasons such as underage status, reduced transportation 
opportunity, or residential housing guidelines. These postulations are not meant to minimize the 
prevalence of substance misuse in the sample, however; this rate confirms the extent of 
maladaptive substance use among the college student population. Results also reveal higher rates 
of alcohol use disorder and cannabis use disorder than is reported for a 2019 national survey of 
substance use (SAMHSA, 2020). Participants in this sample reported rates of elevated alcohol 
and marijuana use that are nearly double what the national rates are.  
 Traits within the Behavioral/Externalizing Dysfunction domain were significantly 
correlated with overall substance use. A strong correlation was found between the MMPI 
Substance Abuse scale and overall substance use as determined by the CAAPE-5, which 
suggests good criterion-related validity of the Substance Abuse scale. Moderate to strong 
correlations between alcohol use and the Disconstraint and Impulsivity scales corroborate the 
literature on disinhibition and impulsivity as risk factors for maladaptive alcohol use. These 
findings are consistent with research indicating young adults with externalizing trait 
characteristics are more likely to engage in maladaptive substance use.  
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 For traits within the Emotional/Internalizing Dysfunction domain, only Demoralization 
was significantly correlated with marijuana use. Given the dearth of research on the association 
between internalizing symptomatology and marijuana misuse, these findings are useful in further 
understanding associations between trait characteristics and marijuana use, which is becoming 
more prevalent. The hypothesis that Disconstraint predicts alcohol use was supported but there 
was no effect of gender on that relationship. In other words, individuals who are more 
disinhibited report increased alcohol use. This finding does not differ between men and women, 
which is inconsistent with research showing men are at higher risk for externalizing disorders 
(Hicks et al., 2007). Given the risk factors associated with substance misuse, especially among 
disinhibited individuals, research on sex differences in patterns of alcohol consumption is needed  
Limitations 
 This study contributes to the understanding of associations between personality and 
psychopathology traits and substance use through the use of two empirically supported measures. 
However, it is not without its limitations. The sample was predominantly composed of 
individuals identifying as White and is therefore not representative of minority populations. 
Participants were college students, which is a crucial population to examine in regard to patterns 
of substance misuse but means findings do not lend generalizability to the general population. 
Future research should involve more diverse samples to generalize these findings to other 
populations.  
 While this study provides some of the first correlations of substance use with the MMPI-
3, the multiple correlation coefficients that were simultaneously calculated in the process of 
testing these hypotheses resulted in increased chances of Type I error. In an attempt to counteract 
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this, a p level of .001 was established for determining significance and a threshold effect size of 
.30 was set for interpretation of the correlation coefficient.  
Clinical Implications 
 This study highlights the high rates of maladaptive substance use seen among the young 
adult population. These findings, combined with research showing increased efficacy of early 
interventions for treatment of substance use disorders, warrant an increased understanding of the 
impact individual differences in personality and psychopathology have on treatment outcomes. 
Previous research on the associations between personality and psychopathology traits and 
maladaptive substance use has outlined the importance of incorporating this knowledge into 
treatment of substance use disorders. Identification of correlations between certain traits and 
misuse of specific substances could assist in providing more targeted treatment interventions for 
individuals with substance use disorders. Research on trait associations in regard to substance 
misuse can inform treatment and assist with the development or modification of approaches that 
could result in increased treatment efficacy. Additionally, this research could prove useful in 
modification of treatment approaches and programs with the goal of increased treatment 
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APPENDIX B: CONSENT FORM 
 
Western Carolina University 
Consent Form to Participate in a Research Study 
 
Thank you for volunteering to participate in this study. This document describes the purposes of the 
study and what will be expected from you, along with some important issues regarding your safety, 
privacy, and confidentiality. These issues will be reviewed with you at the time of your participation, but 
we wanted to provide this information ahead of time as well so that you are fully prepared and know 
exactly what to expect. 
 
Project Title: Improving Prediction of Mental Health Issues in Primary Medical Care Settings 
 
This study is being conducted by: Dr. David McCord and graduate students in his research group. 
(Please note that if your PSY 150 instructor is Ms. Annabel Franz you will not be allowed to participate 
due to conflict of interest.) 
  
Description and Purpose of the Research: You are invited to participate in a research study about the 
development of a brief psychological screening instrument that is designed for routine use in primary 
medical care settings. The current study is intended to explore possible improvements in our ability to 
predict emerging problems in key areas of mental health. The overall goal of this long-term project is to 
create a quick screening test that can help to identify mental health problems very early, so that earlier 
intervention can occur before problems worsen.  
What you will be asked to do: You will be asked to complete a long series of psychological 
questionnaires on a laptop computer. There are eight different questionnaires, one very long, and seven 
much shorter ones. There are no right or wrong answers; you are just asked to answer honestly about 
your thoughts and feelings. Generally, this should take about an hour. Following the questionnaire 
phase you will participate in two different structured interviews, one focused on substance use patterns 
and the other on suicide-related thoughts and feelings. Each of these interviews can take between 5 and 
20 minutes. You are getting 2 full credits in SONA to allow for the time it takes to sign in, get started, 
complete the questionnaires, and then the two interviews. 
 
Risks and Discomforts: We anticipate that your participation in this survey presents no greater risk than 
everyday use of the Internet. However, some of the questions we will ask you as part of this study may 
make you feel uncomfortable.  You may refuse to answer any of the questions, take a break or stop your 
participation in this study at any time.  
We want to emphasize that many of the items on these questionnaires focus on negative emotions such 
as depression, and a fairly large number of items deal more or less directly with suicide-related content. 
If you anticipate that this might cause you too much distress, you should consider declining participation 
in this study.  
Benefits: There are probably no direct benefits to you for participating in this research study.  The study 
is intended to help us better understand the performance of our screening test items and scales so that 
we can continue to improve them. The instrument we are creating can potentially help large numbers of 
people get help sooner for psychological problems. 
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Privacy/Confidentiality/Data Security: The data collected in this research study will be kept 
confidential. Participation in research may involve some loss of privacy. We will do our best to make 
sure that the information about you is kept confidential, but we cannot guarantee total confidentiality. 
You should note, though, that the only “personal” information that will be stored with your test data is 
your Date of Birth, which is not unique to you. Your personal information may be viewed by individuals 
involved in the research and may be seen by people including those collaborating, funding, and 
regulating the study. We will share only the minimum necessary information in order to conduct the 
research. While the information and data resulting from this study may be presented at scientific 
meetings or published in a scientific journal, your name or other personal information will not be 
revealed. 
We will collect much of the research information through Qualtrics, an online survey and data collection 
system. Your participant number allows us to link the completed surveys together, but the only personal 
information included in the Qualtrics data set is Date of Birth. As noted above, following the 
questionnaire part of the study, you will participate in two fairly short face-to-face (on Zoom) interviews. 
The first focuses on substance use history and current patterns, which may take from 5 to 20 minutes. 
The second and final step of the study is a suicide risk interview. Because we are collecting data 
remotely, and because we are very focused on the safety and welfare of our student participants, in 
order to participate you will need to provide us with some personal information in case of an 
emergency.  This information will be entered into a shared OneDrive Excel file.  OneDrive has more 
privacy protections and is a safer storage method than email or even phone conversations.  This Excel 
file will only be accessible to the researcher conducting the initial Zoom session, the researcher 
conducting the suicide risk assessment, and the Principle Investigator on this study (Dr. McCord).  Once 
you have completed the study, if there are no emergency or high-risk factors noted, then all your 
personal information will be deleted.  If there is an emergency or high-risk factors noted, such as 
concern that you have a high likelihood that you would attempt suicide imminently, then your personal 
information will be used to get you help.  Once this has been done, your personal information will be 
deleted.  At that point, there will be no way to connect any of your personal information with any of the 
information you provided during the study – again, you will not be asked to provide any personal 
information, apart from some basic demographic information (e.g., birth date, gender, ethnicity), on any 
of the Qualtrics forms that produce the final data set. 
 
Voluntary Participation: Participation is voluntary and you have the right to withdraw your consent or 
discontinue participation at any time without penalty.  If you choose not to participate or decide to 
withdraw, there will be no impact on your course credit. 
Compensation for Participation: There is no compensation for your volunteer participation apart from 
the SONA credit. 
Contact Information: For questions about this study, please contact Mr. Adam Hicks by email: 
hicksa@wcu.edu.  You may also contact Dr. David McCord the principal investigator and faculty advisor 
for this project, at 828-506-0097 or mccord@wcu.edu. 
If you have questions or concerns about your treatment as a participant in this study, you may contact 
the Western Carolina University Institutional Review Board through the Office of Research 
Administration by calling 828-227-7212 or emailing irb@wcu.edu. All reports or correspondence will 
be kept confidential to the extent possible.   
 
Please retain this document for your records in case you have questions in the future. 
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APPENDIX C: PARTICIPANT RESOURCE SHEET 
 
 
Psychological/Medical Care Services 
 
 Your participation in this survey presents no greater risk than everyday use of the 
Internet. However, some of the questions we asked you as part of this study dealt with sensitive 
subjects such as suicidal ideation and substance use. If you feel distress related to questions 
asked in this study or are experiencing distress in your personal life, we encourage you to contact 
one of the resources listed below. 
 
WCU Counseling and Psychological Services (CAPS) 
Location: 225 Bird Building 
Phone: 
• M-F 8am-5pm: 828.227.7469 
• Crisis clinician on duty weekends and after hours: 828.227.8911 
 
Local Resources 
• Western NC 24-hour crisis line: 888.315.2880 
• Appalachian Community Resources: 888.315.2880 
• Meridian Behavioral Health  
• Address: 44 Bonnie Lane, Sylva, NC 28779 (other locations in Waynesville and 
Franklin) 
• Phone: 828.631.3973 
 
National Emergency Resources 
• National Suicide Prevention Lifeline: 800.273.8255 
• REACH (Sexual Violence Resources) - 828.369.5544 
• Trevor Project (LGBTQ Crisis support) - 866.488.7386 
 
Medical Care 
Harris Regional Hospital 
• Address: 68 Hospital Road, Sylva, NC 28779 
• Phone: 828.586.7000 
Harris Regional Hospital Urgent Care (non-emergency care) 
• Address: 176 Walmart Plaza, Sylva, NC 28779 
• Phone: 828.631.9462 
• 7 days a week – 8am-6:30pm  
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APPENDIX D: TABLES 
 
Table 1 





Emotional/Internalizing Dysfunction (EID) 
Behavioral/Externalizing Dysfunction (BXD) 
Demoralization (RCd) 
Antisocial Behavior (RC4) 
Hypomanic Activation (RC9) 
Helplessness/Hopelessness (HLP) 
Anxiety-Related Experiences (ARX) 





























Sample Demographic Information 
 
 n % 
Gender   
 Male 77 37.6 
 Female 128 62.4 
 Other 0 0 
Age   
     18 104 50.7 
     19 56 27.3 
  20 17 8.3 
  21-25 17 8.3 
     26-51 3 1.5 
Marital Status   
    Never Married 200 97.6 
    Married 5 2.4 
Ethnicity   
    White/Caucasian 175 85.4 
    Black/African American 18 8.8 
    Hispanic/Latinx 18 8.8 
    American Indian/Alaska Native 9 4.4 
    Asian/Asian American 3 1.5 
    Native Hawaiian/Pacific Islander 1 0.5 


































































   Note. N = 205. Mild = 2 – 3 DSM-5 criteria met. Moderate = 4 – 5 DSM-5 criteria met. Severe 














 n % n % n % 
Females 
34 16.6 29 14.1 16 7.8 
Males 
24 11.7 22 10.7 13 6.3 
Total 
58 28.3 51 24.8 29 14.1 
   Note. N = 205. % number out of 205. Data were reported for participants who had both 






MMPI-3 Trait Correlations with Overall Substance Use on CAAPE-5 







Emotional/Internalizing Dysfunction (EID) 
Behavioral/Externalizing Dysfunction (BXD)  
Antisocial Behavior (RC4) 
Hypomanic Activation (RC9) 


























MMPI-3 Trait Correlations with Marijuana Use 








Anxiety-Related Experiences (ARX)  
Helplessness/Hopelessness (HLP) 












 Note. N = 205.  *p < .05. **p < .01.  
 
 






MMPI-3 Trait Correlations with Alcohol Use 
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   .390* 









 Regression Analysis Predicting Alcohol Use from Disconstraint and Gender 




B SE  t p Lower Upper 
Step 1         
  Disconstraint .337 0.033 0.586 10.138 < .001 0.271 0.402 0.580 
  Gender .092 0.229 0.023 0.404 .687 -0.359 0.543 0.023 
Step 2         
  Disconstraint .376 0.111 0.653 3.398  .001 0.158 0.593 0.195 
  Gender .182 0.334 0.046 0.543 .587 -0.478 0.841 0.031 
  Gender X DISC -.025 0.067 -0.071 -0.367 .714 -0.157 0.108 -0.021 
Note. N = 205. CI = confidence interval. Effect size rsp is the semi-partial Pearson correlation.  
 
 
